Home
About
Overview
Sharing Data
ORCID
Help
History (109)
Platelet activation during coronary angioplasty in humans.
Group Practice
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial.
Yeasts
Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics.
See All 109 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics.
Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics. Pharmacogenomics. 2008 Jan; 9(1):5-9.
View in:
PubMed
subject areas
DNA
Drug Evaluation, Preclinical
Humans
Oligonucleotide Array Sequence Analysis
Pharmacogenetics
Sequence Analysis, DNA
authors with profiles
Gerard T. Hardiman